(Total Views: 179)
Posted On: 07/13/2023 11:40:48 AM
Post# of 15407
$HALO News Article - Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche's OCREVUS (ocrelizumab) with Halozyme's ENHANZE Drug Delivery Technology in Patients with Multiple Sclerosis https://marketwirenews.com/news-releases/posi...08521.html
(0)
(0)
My Twitter: WhyteStocks
